Physician profile
Heather Lynn Cooper
NPI 1841268398
$835.43
in general payments reported to CMS, 2019-2025
12 companies · $262 in 2025
The $262 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.14 · 2020: $21.30 · 2023: $228 · 2024: $272 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $369.92 | 2023-2025 | |
| Ironshore Pharmaceuticals INC. | $127.33 | 2019-2024 | |
| Kaleo, INC. | $56.43 | 2019-2023 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $53.87 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $51.97 | 2024-2025 | Gardasil 9, Vaxelis, Rotateq |
| Glaxosmithkline, LLC. | $41.46 | 2024 | Bexsero, Rotarix |
| Seqirus USA INC | $27.23 | 2025 | Flucelvax |
| Alk-Abello, INC | $24.88 | 2023 | Grastek, Ragwitek, Odactra |
| Sanofi-Aventis U.S. LLC | $23.09 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.30 | 2020 | |
| Tris Pharma INC | $21.04 | 2025 | Dyanavel Xr |
| Lundbeck LLC | $16.91 | 2025 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.